Fostemsavir Tromethamine

CHEMBL3301598 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
704.6 g/mol
LogP
Phase
4

This tromethamine salt form of fostemsavir is an attachment inhibitor that prevents HIV from binding to and entering human immune cells. It is used as part of combination antiretroviral therapy for adults with multidrug-resistant HIV who have limited treatment options.

分子量

704.6000 g/mol

TPSA

269.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O.NC(CO)(CO)CO

InChI

InChI=1S/C25H26N7O8P.C4H11NO3/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17;5-4(1-6,2-7)3-8/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38);6-8H,1-3,5H2

Molecular Formula

C29H37N8O11P

HBD / HBA

6 / 15

回転可能結合数

11

重原子数

49

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This tromethamine salt form of fostemsavir is an attachment inhibitor that prevents HIV from binding to and entering human immune cells. It is used as part of combination antiretroviral therapy for adults with multidrug-resistant HIV who have limited treatment options.

Yes, Fostemsavir Tromethamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3301598. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 46892186. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.